FDA Clearance Tracker · P900030-S011
CONTIGEN BARD COLLAGEN IMPLANT
Last checked: Nov 20, 2026Latest source record: Oct 2, 2009 (this decision)Source: openFDAMethods & limitations
Decided
Oct 2, 2009
Approved
Time to decision
213 days
Received Mar 3, 2009. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P900030-S011
- Device name
- CONTIGEN BARD COLLAGEN IMPLANT
- Applicant
- Allergan, Inc.
- Applicant location
- Goleta, CA
- Received
- Mar 3, 2009
- Decided
- Oct 2, 2009
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P900030
Device type
- Device class
- Class III
- Specialty
- GI, Urology & NephrologyUrology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR REVISED DIRECTIONS FOR USE (DFU) THAT INCLUDES INFORMATION FROM THE POST-APPROVAL STUDY ON COHORT C. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME CONTIGEN BARD COLLAGEN IMPLANT AND IS INDICATED FOR USE ONLY IN THE TREATMENT OF URINARY INCONTINENCE DUE TO INTRINSIC SPHINCTER DEFICIENCY (ISD, POOR OR NONFUNCTIONING BLADDER OUTLET MECHANISM) THAT MAY BE HELPED BY A LOCALLY INJECTED BULKING AGENT. CONTIGEN IMPLANT THERAPY SHOULD BE INITIATED ONLY IN PATIENTS WHO HAVE SHOWN NO IMPROVEMENT IN THEIR INCONTINENCE FOR AT LEAST 12 MONTHS.
Source documents
Other decisions for Allergan, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K190674 · Decided Aug 8, 2019 · 146 days after receipt
Device type: Accessories, Soft Lens Products (LPN) · Ophthalmology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.